Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy
about
sameAs
Interactions between kidney disease and diabetes: dangerous liaisonsCirculating biomarkers of glycemia in diabetes management and implications for personalized medicineVariables involved in the discordance between HbA1c and fructosamine: the glycation gap revisitedGlycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes.Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic controlFructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.Serum glucose and fructosamine in relation to risk of cancerEvidence for consistency of the glycation gap in diabetes.Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trialRacial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes.Aerobic neuromuscular electrical stimulation--an emerging technology to improve haemoglobin A1c in type 2 diabetes mellitus: results of a pilot studyGlycated nail proteins as a new biomarker in management of the South Kivu Congolese diabetics.What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes?Estimation of the glycation gap in diabetic patients with stable glycemic control.When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycationHigh bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam StudyGlycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.Association of glycation gap with mortality and vascular complications in diabetes.Clinically significant disagreement between mean blood glucose and estimated average glucose in two populations: implications for diabetes management.Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.Survivors of intensive care with type 2 diabetes and the effect of shared care follow-up clinics: study protocol for the SWEET-AS randomised controlled feasibility study.Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysisDNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.Top-down proteomics of a drop of blood for diabetes monitoring.Spuriously high HbA1c due to the presence of haemoglobin Raleigh: a case report and review of the literature.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.Glycemic control in the clinical management of diabetic patients.Biological variation and hemoglobin A1c: relevance to diabetes management and complications.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Glycated Hemoglobin, Plasma Glucose, and Erythrocyte Aging.Correlation of serum fructosamine and recurrent pregnancy loss: Case-control study.Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study.HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?
P2860
Q26740630-DD163F3C-71D8-43A7-B39F-7CB0FEEB99F2Q27693123-714B080F-861D-4D1C-9C3B-4089C62796B2Q28533840-95B8423C-407A-43D6-B5BE-DDE85D988B76Q33602138-140F0D5B-7E4D-4BA4-983A-4ED9B72AA0C8Q33602143-A710A023-1551-4B5E-BA01-756C4E8D3B00Q33727475-A605B071-03CD-46CF-9CA4-95EA9B046AD2Q33932621-404A2A16-310C-4C41-B17B-64871367244BQ34421046-BFA3D44C-F2E6-437B-8E89-A80052D2706AQ34571468-3796E1DE-5191-42C6-B485-9B8EE40527B6Q35123412-3ADDAE24-6F22-4CFC-BFF9-10E7CFDE76E3Q35419665-DE81FD21-82B1-4BC9-B5F9-D0B44056A62DQ35630701-85BF65E0-C7AF-44B0-8011-DCB6075C5D30Q35869552-A6B9669A-2EE5-4CD9-8788-28F6DA2444A1Q36045032-5BC33E54-F4C3-426E-9E5D-520A50B31B93Q36211930-BB63DA7D-4AF6-4BC1-B944-580C950B76A5Q36302225-FBC03FC0-5834-40DF-A599-CD49A2B6C992Q36426671-DACE0789-9C63-4C4C-929F-72E378A54929Q36426844-15AD8A83-D372-408D-9BD1-2C03EBF22C21Q36622978-89E6EED9-2062-4C09-8E45-D49D00DA83B0Q36842619-9CC355ED-5F39-4686-BD91-9EDD390441FBQ36868093-A3F8186D-391D-4089-A782-CD85571F2F53Q36942120-17087CFA-E3FC-40DE-8CD9-6F72B2DDA711Q36969806-762D82DE-81AA-438A-A563-51E40085C4EEQ37193623-4CF34762-2796-4C6F-A4C5-35575F37173FQ37404475-32CFCA56-A2B3-4F34-985D-2284BC2A8A69Q37404625-4548E632-CF40-483C-BCDC-9D22FF9C0E49Q37498143-7458A58A-3EC4-4996-ACB8-9AFBAF957DF5Q37638849-2C7DEAB7-BE61-40C6-AFAC-EBD7A1CD89BAQ37694160-5558DD21-6781-4E3D-BBF5-DE60F9303BDFQ37714134-41FC796F-C85A-4901-995D-88399964C611Q37815468-33810B74-4F96-47D6-9BD7-4379953DF7D2Q38045278-48B253D1-CA5D-4098-B262-A7B10B809069Q38061853-51DE7AD4-A349-4C48-97C3-C93DE9802191Q38067533-1E78E58E-DCFA-4DFC-A3D0-C7BF3345AC91Q38129464-447719A1-8A25-4B8D-9C6E-5870E0DC96D8Q38182542-FF0C9487-94F9-4BC4-8EA0-0193D1A98002Q39597310-C78340EA-D30B-4C5D-95C9-6BA0FF848F4CQ39953031-05E50A9D-62F9-4A01-9854-93FE86AAB0F7Q42261290-70AD5545-8A2E-4763-B3D1-5ED32ACE64BCQ42331648-9E33C4AC-6649-49BE-8D2F-A5DB7A29EB41
P2860
Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Discordance between HbA1c and ...... lation to diabetic nephropathy
@ast
Discordance between HbA1c and ...... lation to diabetic nephropathy
@en
Discordance between HbA1c and ...... lation to diabetic nephropathy
@nl
type
label
Discordance between HbA1c and ...... lation to diabetic nephropathy
@ast
Discordance between HbA1c and ...... lation to diabetic nephropathy
@en
Discordance between HbA1c and ...... lation to diabetic nephropathy
@nl
prefLabel
Discordance between HbA1c and ...... lation to diabetic nephropathy
@ast
Discordance between HbA1c and ...... lation to diabetic nephropathy
@en
Discordance between HbA1c and ...... lation to diabetic nephropathy
@nl
P2093
P3181
P356
P1433
P1476
Discordance between HbA1c and ...... lation to diabetic nephropathy
@en
P2093
Clinton H Joiner
Robert M Cohen
Thomas C Chenier
Yancey R Holmes
P3181
P356
10.2337/DIACARE.26.1.163
P407
P577
2003-01-01T00:00:00Z